150
BioCryst Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
264
FY23:
327
FY24:
438
FY25:
856
(positive)
Change from FY21 to FY25
millions USD
FY21:
−178
FY22:
−148
FY23:
−104
FY24:
−2.54
FY25:
341
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
365
(positive)
Change from FY21 to FY25
millions USD
FY21:
−182
FY22:
−244
FY23:
−226
FY24:
−87.0
FY25:
267
(positive)
Change from FY21 to FY25
millions USD
FY21:
−184
FY22:
−247
FY23:
−227
FY24:
−88.9
FY25:
264
All amounts in millions USD